These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7614851)

  • 1. Cellular biology of tubulointerstitial growth.
    Wolf G; Neilson EG
    Curr Top Pathol; 1995; 88():69-97. PubMed ID: 7614851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia.
    Wolf G; Neilson EG
    Kidney Int; 1991 Mar; 39(3):401-20. PubMed ID: 1648145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury.
    Wolf G
    Miner Electrolyte Metab; 1995; 21(4-5):303-16. PubMed ID: 7565479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating factors of renal tubular hypertrophy.
    Wolf G
    Clin Investig; 1993 Oct; 71(10):867-70. PubMed ID: 8305851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular hypertrophy induced by angiotensin II.
    Wolf G; Ziyadeh FN
    Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different regulation systems of cell cycle events (dysregulation of these events in the tumoral cell)].
    Colomb E; Martin PM
    Bull Cancer; 1991 Jan; 78(1):1-21. PubMed ID: 2021683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophy and hyperplasia of renal tubular interstitial cells--regulatory factors].
    Kanetake H; Igawa T; Kanda S; Saito Y
    Nihon Rinsho; 1995 Aug; 53(8):1894-9. PubMed ID: 7563625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression.
    Ong AC; Fine LG
    Am J Kidney Dis; 1994 Feb; 23(2):205-9. PubMed ID: 8311076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of renal hypertrophy: role of p27Kip1.
    Wolf G
    Kidney Int; 1999 Oct; 56(4):1262-5. PubMed ID: 10504470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive factors and tubulointerstitial injury.
    Wolf G
    Kidney Blood Press Res; 1999; 22(1-2):62-70. PubMed ID: 10352409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of proto-oncogenes in coronary restenosis.
    Muller DW
    Prog Cardiovasc Dis; 1997; 40(2):117-28. PubMed ID: 9327828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells.
    Zeisberg M; Maeshima Y; Mosterman B; Kalluri R
    Am J Pathol; 2002 Jun; 160(6):2001-8. PubMed ID: 12057905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells.
    Li A; Wang J; Zhu D; Zhang X; Pan R; Wang R
    Free Radic Res; 2015; 49(9):1095-113. PubMed ID: 25968940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of diabetic renal hypertrophy.
    Wolf G; Ziyadeh FN
    Kidney Int; 1999 Aug; 56(2):393-405. PubMed ID: 10432377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
    Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
    J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.
    Djudjaj S; Martin IV; Buhl EM; Nothofer NJ; Leng L; Piecychna M; Floege J; Bernhagen J; Bucala R; Boor P
    J Am Soc Nephrol; 2017 Dec; 28(12):3590-3604. PubMed ID: 28801314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy.
    Abdel-Wahab N; Weston BS; Roberts T; Mason RM
    J Am Soc Nephrol; 2002 Oct; 13(10):2437-45. PubMed ID: 12239232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.